Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
17-OHPC in Early-onset Preeclampsia
NCT04077853Phase 4Completed
- Sponsor
- Assiut University
- Start
- Dec 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxyprogesterone caproate in preeclampsia, sponsored by Assiut University. Started Dec 2019; status: completed.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04077853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04077853.